Please assess the completion status of the following clinical trial:

Trial Title: Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. No prior treatment for esophageal cancer~2. No prior radiation to the chest or upper abdominal area~3. No prior treatment with an EGFR inhibitor or an anti-angiogenic agent~4. Disease should be limited to the esophagus and regional lymph nodes -~Exclusion Criteria:~1. History of stroke~2. History of heart attack~3. Inadequately controlled high blood pressure

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Bevacizumab (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).